$ENVA

Enova International, Inc. (ENVA) Hits Fresh High: Is There Still Room to Run?

Enova International (ENVA) shares rose 6.9% over the past month and hit a new 52-week high of $252.71. The stock has beaten the Zacks Consensus Estimate in each of the last four quarters. In its July 23, 2026 report, EPS was $4.31 vs $3.99 consensus. FY2026 EPS is forecast at $16.43 on $3.74 revenue; FY2027 EPS $20.67 on $4.34. Valuation shows 15.3X FY EPS vs 11X peers; Zacks Rank #2 (Buy).

Original reporting
Published Jul 28, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 7:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Enova International, Inc. (ENVA) Hits Fresh High: Is There Still Room to Run? — source image
Decision brief

The 30-second read

$ENVABullishLow
01

Why it matters

ENVA’s latest reported EPS beat and the stock’s move to a 52-week high support a momentum-positive narrative, but the lack of fresh guidance or new catalyst reduces incremental trading edge.

02

Market read

Traders get a snapshot of ENVA’s earnings-surprise track record and premium valuation, but no new forward catalyst beyond expectations.

03

What to watch

The article does not provide credit-loss trends, funding-cost changes, or guidance updates, which are typically key for lenders and can dominate valuation at cycle peaks.

Relevance 4/10Novelty 4/10Timing: post-July 23 earnings recap while stock is at a new 52-week high

Background

The article highlights ENVA’s recent outperformance, repeated earnings beats, and valuation versus peer averages, using Zacks metrics.

Company-level read

Ticker impact

$ENVABullishMedium confidence
Context

Enova hit a new 52-week high after reporting EPS of $4.31 vs $3.99 consensus on July 23, 2026.

Expected impact

Near-term upside may be capped unless the next earnings cycle continues to beat estimates; otherwise, valuation premium could invite a pullback.

Evidence & confidence

The only concrete, decision-relevant datapoints are the latest EPS beat and the stated valuation premium (15.3x forward EPS, 18.8x trailing cash flow) alongside a Zacks Rank #2 (Buy). No new guidance or balance-sheet/regulatory catalyst is provided.

Market effects

Limited read-across; the piece is primarily single-name performance and valuation framing rather than a sector catalyst.

None stated.

None stated.

Counterpoint

At a new 52-week high with a premium multiple versus peers, ENVA could see mean reversion if future earnings surprises narrow.

Key entities

  • Enova International, Inc.

    Subject of the article; stock at new 52-week high and described as having beaten consensus in each of the last four quarters.

  • Zacks Consensus Estimate

    The article cites consensus EPS of $3.99 for the July 23, 2026 earnings report.

  • Zacks Rank

    States ENVA has a Zacks Rank of #2 (Buy).

Related articles

$OPFIMed

OppFi and Enova Bank Deals Put Lending Under Scrutiny

Attorneys general asked the Federal Reserve, OCC and FDIC to deny banking privileges tied to OppFi’s $130M acquisition of BNCCORP and BNC National Bank and Enova’s proposed acquisition of Grasshopper Bancorp and Grasshopper Bank. AGs allege bank partnerships bypass state loan-rate caps and cite high rates and charge-offs. OppFi and Enova project deposit and revenue synergies and EPS accretion.

$ENVAMed

ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies

Enova International Inc. (NYSE: ENVA) shares rose about 9% after Q2 results and guidance-related optimism. The company reported adjusted EPS of $4.31 vs $3.96 consensus and revenue of $928.9M vs $764M prior year, with operating cash flow of $544M and $531.4M free cash flow. Analysts reportedly raised price targets to $257-$280, citing the Grasshopper Bank acquisition and improving credit metrics.

$ENVAMedAI 8/10

Enova International Stock Jumps After Powerful Q2 Beat

Enova International Inc. (NYSE: ENVA) shares rose about 9% during the week after the company reported Q2 2026 results and raised guidance. Adjusted EPS was $4.31 versus $3.96 expected, with revenue up to $928.9M from $764M. Management cited record $5.5B loans, improving margins, and ongoing share repurchases.

$ENVAMed

ENVA Jumps As Enova Earnings Beat Fuels Bullish Targets

Enova International Inc. (NYSE: ENVA) shares rose about 9% after its Q2 2026 results. The company reported adjusted EPS of $4.31 versus $3.23 a year earlier and revenue of $928.9M versus $764M, alongside a consumer credit outlook. Analysts cited bullish targets of $257 to $280 and support near $230.

$ENVAMedAI 8/10

Enova International Signals Strong Growth and Rising EPS

Enova International (ENVA) reported Q2 results and said consolidated originations rose 27% YoY to nearly $2.3B and total revenue rose 22% to $929M. Adjusted EPS increased 33% YoY to $4.31. Credit metrics improved, with net charge-offs at 7.3%. Management raised Q3 and 2026 guidance and noted the pending Grasshopper Bank deal awaits regulatory approval.

$ENVAMedAI 8/10

Enova Reports Second Quarter 2026 Results

Enova International (NYSE: ENVA) reported Q2 2026 results. Total revenue rose 22% to $929 million. Diluted EPS was $4.00, up 40%, and adjusted EPS was $4.31, up 33%. Credit metrics stayed strong, with net charge-offs at a 7.3% ratio and net revenue margin at 61%. Enova also repurchased $19 million of stock and reported $929 million liquidity at June 30.